Haleon PLC Sponsored ADR $HLN Shares Bought by Ballentine Partners LLC

Ballentine Partners LLC raised its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 15.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,135 shares of the company’s stock after purchasing an additional 4,515 shares during the quarter. Ballentine Partners LLC’s holdings in Haleon were worth $354,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Bartlett & CO. Wealth Management LLC raised its stake in Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after purchasing an additional 1,491 shares during the period. Banque Transatlantique SA acquired a new stake in Haleon during the 1st quarter valued at $27,000. Opal Wealth Advisors LLC acquired a new stake in Haleon during the 1st quarter valued at $29,000. Ransom Advisory Ltd acquired a new stake in Haleon during the 1st quarter valued at $31,000. Finally, Deutsche Bank AG raised its stake in Haleon by 267.8% during the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after purchasing an additional 2,276 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Trading Up 1.3%

NYSE HLN opened at $8.84 on Monday. Haleon PLC Sponsored ADR has a 1-year low of $8.71 and a 1-year high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $39.46 billion, a PE ratio of 22.65, a price-to-earnings-growth ratio of 2.61 and a beta of 0.23. The firm’s fifty day simple moving average is $9.58 and its 200-day simple moving average is $10.11.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a dividend of $0.0555 per share. The ex-dividend date of this dividend was Friday, August 15th. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. This represents a yield of 190.0%. Haleon’s dividend payout ratio (DPR) is currently 28.21%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Finally, The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.